Raw Data Library
About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User Guide
Green Science
​
​
EN
Kurumsal BaşvuruSign inGet started
​
​

About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User GuideGreen Science

Language

Kurumsal Başvuru

Sign inGet started
RDL logo

Verified research datasets. Instant access. Built for collaboration.

Navigation

About

Aims and Scope

Advisory Board Members

More

Who We Are?

Contact

Add Raw Data

User Guide

Legal

Privacy Policy

Terms of Service

Support

Got an issue? Email us directly.

Email: info@rawdatalibrary.netOpen Mail App
​
​

© 2026 Raw Data Library. All rights reserved.
PrivacyTermsContact
  1. Raw Data Library
  2. /
  3. Publications
  4. /
  5. COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients

Verified authors • Institutional access • DOI aware
50,000+ researchers120,000+ datasets90% satisfaction
Article
en
2023

COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients

0 Datasets

0 Files

en
2023
Vol 271 (2)
Vol. 271
DOI: 10.1007/s00415-023-12084-4

Get instant academic access to this publication’s datasets.

Create free accountHow it works

Frequently asked questions

Is access really free for academics and students?

Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.

How is my data protected?

Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.

Can I request additional materials?

Yes, message the author after sign-up to request supplementary files or replication code.

Advance your research today

Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.

Get free academic accessLearn more
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
Access Research Data

Join our academic network to download verified datasets and collaborate with researchers worldwide.

Get Free Access
Institutional SSO
Secure
This PDF is not available in different languages.
No localized PDFs are currently available.
Massimo Filippi
Massimo Filippi

Institution not specified

Verified
Alvino Bisecco
Federica Matrone
Marco Capobianco
+58 more

Abstract

Despite the significant extension of OCR infusion interval during the first wave of pandemic in Italy, a very small incidence of clinical/radiological events was observed, thus suggesting durable efficacy of OCR, as well as the absence of rebound after its short-term suspension.

How to cite this publication

Alvino Bisecco, Federica Matrone, Marco Capobianco, Giovanna De Luca, Massimo Filippi, Franco Granella, Giacomo Lus, Girolama Alessandra Marfia, Massimiliano Mirabella, Francesco Patti, María Trojano, Agnese Mascolo, Massimiliano Copetti, Gioacchino Tedeschi, Antonio Gallo, Simona Malucchi, Maria Talentacci, Valentina Tomassini, D. Farina, Lucia Moiola, Agostino Nozzolillo, Alessandro Franceschini, Matteo Minetti, Elisabetta Signoriello, Giuseppe Romano, Mario Risi, Alessandro d’Ambrosio, Doriana Landi, Carolina Gabri Nicoletti, Assunta Bianco, Matteo Lucchini, Clara Grazia Chisari, Simona Toscano, Damiano Paolicelli, Pietro Iaffaldano, Matilde Inglese, Maria Cellerino, Paolo Bellantonio, Roberta Fantozzi, Giuseppe Salemi, Paolo Ragonese, Maura Danni, G. Coniglio, Diana Ferraro, Giorgia Teresa Maniscalco, Antonella Conte, Paola Cavalla, Marika Vianello, Daniela Cargnelutti, Maurizia Gatto, Ardito Buonaventura, Alessandra Lugaresi, Maria Pia Amato, Paola Gazzola, Rosa Iodice, Ilaria Pesci, Sara Montepietra, Carlo Pozzilli, Elisabetta Ferraro, Mauro Zaffaroni, Davide Nasuelli (2023). COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients. , 271(2), DOI: https://doi.org/10.1007/s00415-023-12084-4.

Related publications

Why join Raw Data Library?

Quality

Datasets shared by verified academics with rich metadata and previews.

Control

Authors choose access levels; downloads are logged for transparency.

Free for Academia

Students and faculty get instant access after verification.

Publication Details

Type

Article

Year

2023

Authors

61

Datasets

0

Total Files

0

Language

en

DOI

https://doi.org/10.1007/s00415-023-12084-4

Join Research Community

Access datasets from 50,000+ researchers worldwide with institutional verification.

Get Free Access